Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

Holdings in Q1 2025

Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.

Institution overview
Positions
37
+1 vs. Q4 2024
Portfolio value
$875.7M
−$169.5M (−16.2%) vs. Q4 2024
Filed
May 15, 2025
SEC
Holdings of First Light Asset Management, LLC in Q1 2025
SecurityClassSharesValue% of portfolioShare changeActionHistory
ANABAnaptysbio, IncCOM4,633,602$86.1M9.8%+3,764,720+433.3%AddedHistory
AXGNAxogen, Inc.COM4,474,215$82.8M9.5%−32,580−0.7%ReducedHistory
CNTACentessa Pharmaceuticals plcSPONSORED ADS4,874,124$70.1M8.0%−931,060−16.0%ReducedHistory
NEONeogenomics IncCOM NEW6,042,822$57.3M6.5%+2,875,237+90.8%AddedHistory
TWSTTwist Bioscience CorpCOM1,218,699$47.8M5.5%−7,556−0.6%ReducedHistory
HCATHealth Catalyst, Inc.COM10,436,807$47.3M5.4%+5,195,686+99.1%AddedHistory
ATRCAtriCure, Inc.COM1,314,718$42.4M4.8%−654,503−33.2%ReducedHistory
EWTXEdgewise Therapeutics, Inc.COM1,852,290$40.8M4.7%+1,071,651+137.3%AddedHistory
PHLTPerformant Healthcare IncCOM11,693,033$34.6M4.0%+346,384+3.1%AddedHistory
IRTCiRhythm Holdings, Inc.COM325,046$34.0M3.9%−105,454−24.5%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM855,419$28.7M3.3%−30,034−3.4%ReducedHistory
VERAVera Therapeutics, Inc.CL A1,175,879$28.2M3.2%−85,367−6.8%ReducedHistory
MDXGMimedx Group, Inc.COM3,453,074$26.2M3.0%+109,213+3.3%AddedHistory
RAREUltragenyx Pharmaceutical Inc.COM632,033$22.9M2.6%−131,574−17.2%ReducedHistory
SIBNSI-BONE, Inc.COM1,612,408$22.6M2.6%+475,426+41.8%AddedHistory
XENEXenon Pharmaceuticals Inc.COM627,904$21.1M2.4%−532,676−45.9%ReducedHistory
NPCENeuroPace IncCOM1,584,048$19.5M2.2%+1,584,048NewHistory
ALHCAlignment Healthcare, Inc.COM956,441$17.8M2.0%+956,441NewHistory
JANXJanux Therapeutics, Inc.COM658,824$17.8M2.0%+345,042+110.0%AddedHistory
ESTAEstablishment Labs Holdings Inc.COM336,870$13.7M1.6%+336,870NewHistory
BFLYButterfly Network, Inc.COM CL A5,505,649$12.6M1.4%+1,511,029+37.8%AddedHistory
GHGuardant Health, Inc.COM271,115$11.5M1.3%−38,274−12.4%ReducedHistory
KRMDKORU Medical Systems, Inc.COM4,454,926$11.3M1.3%−1,460,508−24.7%ReducedHistory
RGENRepligen CorpCOM87,850$11.2M1.3%+5,395+6.5%AddedHistory
ELDNEledon Pharmaceuticals, Inc.COM2,328,768$7.89M0.9%00.0%UnchangedHistory
MASS908 Devices Inc.COM1,701,095$7.62M0.9%+1,701,095NewHistory
TMDXTransMedics Group, Inc.COM107,860$7.26M0.8%−31,897−22.8%ReducedHistory
OSCROscar Health, Inc.CL A522,302$6.85M0.8%−24,520−4.5%ReducedHistory
FNAParagon 28, Inc.COM500,000$6.53M0.7%−10,080,467−95.3%ReducedHistory
EVHEvolent Health, Inc.CL A585,436$5.54M0.6%+531,816+991.8%AddedHistory
INSMINSMED IncCOM PAR $.0168,153$5.20M0.6%−402,039−85.5%ReducedHistory
TNDMTandem Diabetes Care IncCOM NEW245,257$4.70M0.5%−46,860−16.0%ReducedHistory
PODDInsulet CorpStock17,022$4.47M0.5%−16,799−49.7%ReducedHistory
PCVXVaxcyte, Inc.COM94,420$3.57M0.4%+94,420NewHistory
SENSSenseonics Holdings, Inc.COM4,657,505$3.06M0.3%−1,774,294−27.6%ReducedHistory
Direxion Daily S&P Biotech Bear 3X Shares25490K745Common Stocks140,282$2.30M0.3%+140,282New–
GPCRStructure Therapeutics Inc.SPONSORED ADS132,380$2.29M0.3%−266,475−66.8%ReducedHistory

Sold out since Q4 2024 (5)

Positions held at the end of Q4 2024 that are gone from this filing.

Positions of First Light Asset Management, LLC sold out since Q4 2024
SecurityClassShares in Q4 2024Value in Q4 2024% of portfolio in Q4 2024History
PLRXPliant Therapeutics, Inc.COM1,681,110$22.1M2.1%History
KYMRKymera Therapeutics, Inc.COM383,310$15.4M1.5%History
NTRANatera, Inc.COM93,088$14.7M1.4%History
DYNDyne Therapeutics, Inc.COM420,431$9.91M0.9%History
iShares Russell 2000 Growth ETF464287648ETF1,208$347.7K<0.1%–